Cerebral ischemia: Pharmacological bases of drug therapy

Dementia and Geriatric Cognitive Disorders

Volumn 7, Issue 3, 1996, Pages 161-168

  Ferger, Dorothee ^a   Krieglstein, Josef ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Calcium homeostasis; Cerebral ischemia; Glutamate; Neuroprotection; Oxygen radicals

Indexed keywords

ADENOSINE RECEPTOR STIMULATING AGENT; CALCIUM ANTAGONIST; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; OXYGEN RADICAL; SCAVENGER; SEROTONIN 1A AGONIST;

ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN METABOLISM; CALCIUM HOMEOSTASIS; ENERGY METABOLISM; NEUROPROTECTION; PRIORITY JOURNAL;

ADENOSINE; BRAIN; BRAIN ISCHEMIA; CALCIUM; CALCIUM CHANNEL BLOCKERS; ENERGY METABOLISM; FREE RADICAL SCAVENGERS; GLUTAMATES; HOMEOSTASIS; HUMANS; REACTIVE OXYGEN SPECIES; SEROTONIN AGONISTS;

EID: 0029866719     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106872     Document Type: Article

References (37)

1. Krieglstein G, Kricglstcin J, Stock R: Suitability of the isolated perfused rat brain for studying effects on cerebral metabolism. Naunyn Schmiedebergs Arch Pharmacol 1972;275: 124-134.
2. Dirks B, Hanke J, Krieglstein J, Slock R, Wickop G: Studies on the linkage of energy metabolism and neuronal activity in the isolated perfused rat brain. J Neurochem 19SO;35:311-317.
3. Hanke J, Krieglstein J: Über die Mechanismen der protektiven Wirkung von Methohcxital auf den cerebralen Energiest of Twechsel. Arzneimittelforschung 1982:6:620-625.
4. Kirino T: Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982:239:57-69.
5. Smith ML, Bendek G, Dahlgren M, Roosen I, Wieloch T, Siesjö BK: Models for studying long-term recovery following forebrain ischemia in the rat. A two vessel occlusion model. Acta Neurol Scand 1984:69:385-401.
6. Siesjö B: Brain Energy Metabolism. Chichester, Wiley, 1978.
7. Krieglstein J, Weber J: Calcium entry blockers protect brain energy metabolism against ischemic damage: in Longmuir JS (ed): Oxygen Transport to Tissue VIII. New York, Plenum Press. 1986. pp 243-251.
8. Siesjö BK: Cell damage in the brain: A speculative synthesis. J Cereb Blood Flow Metab 1981; 1:155-185.
9. Nowycky MC, Fox AP, Tsien RW: Three types of neuronal calcium channels with different calcium antagonist sensitivity. Nature 1985: 316:440-443.
10. Zelis R, Moore R: Recent insights into the calcium currents. Circulation 1989:80 (suppl IV): 14-16.
11. Scott RH, Pearson H, Dolphin AC: Aspects of vertebrate neuronal voltage-activated calcium currents and their regulation. Prog Neurobiol 1991:36:485-520.
12. 2< channels. Trends Pharmacol Sei 1991;12:349-354.
13. Rami A, Rabié A, Thomassct M, Krieglstein J: Calbindin-D2»K and ischemic damage of pyramidal cells in rat hippocampus. J Ncurosci Res 1992:31:89-95.
14. Nicholls D, Attwell D: The release and uptake of excitatory amino acids. Trends Pharmacol Sci 1990;11:462-468.
15. Siesjd BK, Bengtsson F: Calcium, calcium antagonists. and ischemic cell death in the brain: in Krieglstein J (ed): Pharmacology of Cerebral Ischemia. Stuttgart. Wissenschaftlichc Vcrlags-gcscllschaft, 1988. pp 23-29.
16. Krieglstein J, Nuglisch J: Metabolic disorders as consequences of drug-induced energy deficits: in Herken H. Hucho F (eds): Handbook of Experimental Pharmacology. Selective Neurotoxicity. Berlin. Springer. 1992. vol 102, pp 111-139.
17. Katz AM, Messinco FC: Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res 1981:48: 1-16.
18. Nuglisch J, Karkoutly C, Mennel HD, Rossberg C, Krieglstein J: Protective effect of ni-modipine against ischemic neuronal damage in rat hippocampus without changing postisch-emic cerebral blood flow. J Cereb Blood Bow Metab 1990;10:654-659.
19. Choi DW: Methods for antagonizing glutamate neurotoxicity. Cerebrovasc Brain Metab Rev 1990;2:105-147.
20. Iino M, Ozawa S, Tsuzuki K: Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones. J Physiol (Lond) 1990;424:151-165.
21. 2* clcvat ion in cultured hippocampal neurones. Neurosci Res 1990;9:103-113.
22. Brorson JR, Bleakman D, Chard PS, Miller RJ: Calcium directly permeates kainate/a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in cultured cerebellar Purkinje neurons. Mol Pharmacol 1992;41:603-608.
23. Sorimachi M: Calcium permeability of non-N-methyl-D-asparlate receptor channels in immature cerebellar purkinje cells: Studies using fura-2 microfluorometry. J Neurochem 1993; 60:1236-1243.
24. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 1991;252:851-853.
25. Shcardown MJ, Nielson EO, Hansen AJ, Jacobsen P, Honorc T: 2,3-Dihydroxy-6-nitro-7-sulfamoyl-bcnzo(F)qumoxalinc: A ncuropro-tcctant for cerebral ischemia. Science 1990; 247:571-574.
26. Lippert K, Welsch M, Krieglstein J: The neuro-protective effect of combined treatment with dizocilpinc and NBQX in vitro and in vivo; in Krieglstein J, Obcrpichler-Schwcnk H (eds): Pharmacology of Cerebral Ischemia. Stuttgart. Wissenschaftliche Vcrlagsgcscllschaft, 1992, pp 147-153.
27. Siesjö BK, Agardh CD, Bengtsson F: Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1989;1:165-211.
28. Halliwell B, Gutteridge JMC: Oxygen toxicity, oxygen radicals, transition metals and disease. BiochcmJ 1984;219:1-14.
29. Jesberger JA, Richardson JS: Oxygen free radicals and brain dysfunction. Int J Ncurosci 1991;57:1-17.
30. Kirsch JR, Phelan AM, Lange DG, Traystman RJ: Repcrfusion-induced free radical formation following global ischemia. Pediatr Res 1987:21:202A.
31. Prehn JHM, Karkoutly C, Nuglisch J, Pcruchc B, Krieglstein J: Dihydrolipoate reduces neuronal injury' after cerebral ischemia. J Cereb Blood Bow Metab 1992;12:78-87.
32. Hall ED: Lazaroids: Efficacy and anti-oxidant mechanism in experimental cerebral ischemia; in Krieglstein J, Oberpichler H (eds): Pharmacology of Cerebral Ischemia 1990. Stuttgart. Wissenschaftliche Verlagsgesellschaft, 1990, pp 343-350.
33. Beck T, Bielenberg GW: The effects of two 21-aminosteroids on overt infarct size 48 hours after middle cerebral artery occlusion in the rat. Brain Res 1991;560:159-162.
34. 1A receptor agonists in rodent models of focal and global cerebral ischemia. Eur J Pharmacol 1991:203: 213-222.
35. Karkoutly C, Backhauss C, Nuglisch J, Krieglstein J: The measurement of the infarct area after middle cerebral artery occlusion in the mouse: A screening model; in Krieglstein J, Obcrpichler H (eds): Pharmacology of Cerebral Ischemia. Stuttgart, Wissenschaftliche Verlags-gcscllschaft, 1990, pp 63-70.
36. Rischke R, Krieglstein J: Protective effect of vinpocetine against brain damage caused by ischemia. Jap J Pharmacol 1991;56:349-356.
37. Krieglstein J, Rischkc R: Vinpocetine increases the neuroprotective effect of adenosine in vitro. Eur J Pharmacol 1991;205:7-10.